common.study.topics.clinical

Azithromycin Treatment for the Airway Microbiome in Asthma

common.study.values.description

Azithromycin Treatment for the Airway Microbiome in Asthma

The purpose of this study to determine whether the bacteria inside the lungs of people with asthma can be modified (changed) if they are given an antibiotic and if this change is associated with an improvement in asthma symptoms.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Azithromycin

8 weeks of Azithromycin (250 mg) once daily by mouth

Drug - Placebo

Placebo

participant.views.study.view.additional

participant.views.study.view.scientific-title

The AZITRAMBA Trial: Azithromycin Treatment for the Airway Microbiome in Asthma

common.study.values.clinical-trial-id

NCT03736629

participant.views.study.view.id

azpB8d